NasdaqGS:LFSTHealthcare
What LifeStance Health Group (LFST)'s Profit Return, Buyback Plan, and Stock Offerings Mean For Shareholders
In late February 2026, LifeStance Health Group reported fourth-quarter 2025 revenue of US$382.2 million and net income of US$11.7 million, issued 2026 revenue guidance of US$1.615 billion to US$1.655 billion, authorized a US$100 million share repurchase plan, and filed follow-on and shelf registrations for new common stock offerings.
Together, the return to profitability, expanded capital markets activity, and planned buybacks highlight how LifeStance is actively reshaping its balance...